Ascletis Pharma Eulerpool Nyheter

Ascletis Pharma Aksje Nyheter

Ascletis Pharma blir fulgt av mange journalister og investorer over hele verden. De nyeste Ascletis Pharma nyhetene presenterer vi her.

• ·

  SeekingAlpha
  Sagimet: More Than Just A MASH Drug Development Biotech
• ·

  Yahoo
  Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne
• ·

  Yahoo
  Ascletis Announces Promising Results from a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate ASC47 for the Treatment of Obesity
• ·

  Yahoo
  Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity
• ·

  SeekingAlpha
  Sagimet Biosciences' Denifanstat Remains A Strong Buy Despite Eli Lilly's Tirzepatide
• ·

  Yahoo
  Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024